Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Infectious Diseases
Volume 2018, Article ID 1951936, 4 pages
https://doi.org/10.1155/2018/1951936
Case Report

Acute Seronegative Toxoplasma gondii Hepatitis Allergic to First-Line Treatment

1Department of Internal Medicine, Christus Muguerza Hospital Alta Especialidad, Universidad de Monterrey, San Pedro Garza García, NL 64060, Mexico
2Department of Gastroenterology, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, San Nicolás de los Garza, NL 64460, Mexico
3Department of Pathology, Christus Muguerza Hospital Alta Especialidad, Universidad de Monterrey, San Pedro Garza García, NL 64060, Mexico
4Epidemiologic Hospital Coordination, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, San Nicolás de los Garza, NL 64460, Mexico

Correspondence should be addressed to Adrián Camacho-Ortiz; moc.oohay@dm_ohcamaca

Received 22 January 2018; Revised 16 February 2018; Accepted 1 March 2018; Published 1 April 2018

Academic Editor: Larry M. Bush

Copyright © 2018 Fernando De la Garza-Salazar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. M. Tenter, A. R. Heckeroth, and L. M. Weiss, “Toxoplasma gondii: from animals to humans,” International Journal for Parasitology, vol. 30, no. 12, pp. 1217–1258, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. M. de la Luz Galvan-Ramirez, R. Troyo, S. Roman, C. Calvillo-Sanchez, and R. Bernal-Redondo, “A systematic review and meta-analysis of Toxoplasma gondii infection among the Mexican population,” Parasites & Vectors, vol. 5, no. 1, p. 271, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Caballero-Ortega, F. J. Uribe-Salas, C. J. Conde-Glez et al., “Seroprevalence and national distribution of human toxoplasmosis in Mexico: analysis of the 2000 and 2006 National Health Surveys,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 106, no. 11, pp. 653–659, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. O. Velasco-Castrejon, B. Salvatierra-Izaba, J. L. Vardespino et al., “Seroepidemiología de la toxoplasmosis en México,” Salud Publica de Mexico, vol. 34, no. 2, pp. 222–229, 1992. View at Publisher · View at Google Scholar
  5. T. Vischer, C. Bernheim, and E. Engelbrecht, “Two cases of hepatitis due to Toxoplasma gondii,” The Lancet, vol. 290, no. 7522, pp. 919–921, 1967. View at Publisher · View at Google Scholar
  6. J. Frenkel and J. Remington, “Hepatitis in toxoplasmosis,” New England Journal of Medicine, vol. 302, no. 3, pp. 178-179, 1980. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Roca, C. Calabuig, and M. Arenas, “Toxoplasmosis and hepatitis,” Medicina Clínica, vol. 99, no. 15, p. 595, 1992. View at Google Scholar
  8. C. Duvic, M. Herody, F. Didelot, and G. Nedelec, “Acute toxoplasmic hepatitis in an immunocompetent adult,” Proceedings of the Annales de Medecine Interne, vol. 31, no. 4, pp. 323-324, 1996. View at Google Scholar
  9. N. Doğan, S. Kabukçuoğlu, and E. Vardareli, “Toxoplasmic hepatitis in an immunocompetent patient,” Türkiye Parazitoloji Dergisi, vol. 31, no. 4, pp. 260–263, 2007. View at Google Scholar
  10. A. Atilla, S. Aydin, A. N. Demirdöven, and S. S. Kiliç, “Severe toxoplasmic hepatitis in an immunocompetent patient,” Japanese Journal of Infectious Diseases, vol. 68, no. 5, pp. 407–409, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. J. A. Krick and J. S. Remington, “Toxoplasmosis in the adult—an overview,” New England Journal of Medicine, vol. 298, no. 10, pp. 550–553, 1978. View at Publisher · View at Google Scholar · View at Scopus
  12. A. B. Weitberg, J. C. Alper, I. Diamond, and Z. Fligiel, “Acute granulomatous hepatitis in the course of acquired toxoplasmosis,” New England Journal of Medicine, vol. 300, no. 19, pp. 1093–1096, 1979. View at Publisher · View at Google Scholar · View at Scopus
  13. I. Tiwari, C. Rolland, and A. Popple, “Cholestatic jaundice due to toxoplasma hepatitis,” Postgraduate Medical Journal, vol. 58, no. 679, p. 299, 1982. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Redondo, A. Sanchez, and M. Galvan-Ramirez, Diagnostic of Opportunistic Parasites in Liver Transplantation, Parasitology research trends, New York, NY, USA, 2010.
  15. M. Galván-Ramírez, C. F. Orozco, and J. S. Mancilla, “Seroepidemiology of Toxoplasma gondii in workers of slaughterhouse in Zapopan, Jalisco,” International Journal of Infectious Diseases, vol. 12, p. e384, 2008. View at Publisher · View at Google Scholar
  16. O. Villard, B. Cimon, C. L’Ollivier et al., “Serological diagnosis of Toxoplasma gondii infection: recommendations from the French National Reference Center for Toxoplasmosis,” Diagnostic Microbiology and Infectious Disease, vol. 84, no. 1, pp. 22–33, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. L. S. Garcia and D. A. Bruckner, Diagnostic Medical Parasitology, ASM Press, Washington, DC, USA, 2001.
  18. P. H. Alday and J. S. Doggett, “Drugs in development for toxoplasmosis: advances, challenges, and current status,” Drug Design, Development and Therapy, vol. 11, p. 273, 2017. View at Publisher · View at Google Scholar · View at Scopus